STAA Q2 2023 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q2 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$92M+13.8% YoY

Gross Profit

$71M76.6% margin

Operating Income

$9M9.3% margin

Net Income

$6M6.6% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+25.5%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$9M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$441M

Total Liabilities

$87M

Stockholders' Equity

$354M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$92M	$81M	+13.8%
Gross Profit	$71M	$64M	+10.7%
Operating Income	$9M	$17M	-49.5%
Net Income	$6M	$13M	-53.5%

Revenue Segments

Implantable Collamer Lenses

$93M100%

Cataract Intraocular Lenses

$40,0000%